Monthly Archives: February 2015

Deutsche Bank Maintains a Buy Rating on Ross Stores

In a report released today, Michael Baker from Deutsche Bank maintained a Buy rating on Ross Stores (NASDAQ: ROST), with a price target of $115. The company’s shares opened today at $104.73. Currently, the analyst consensus on Ross Stores is

Relypsa Inc Recieves New Rating from Top Analyst

Wedbush analyst Liana Moussatos reiterated an Outperform rating on Relypsa Inc (NASDAQ: RLYP) yesterday and set a price target of $63. The company’s shares opened today at $39. Moussatos commented, “Relypsa raised approximately $141.1 million (net base)/ $162.3 million (net

Procera Receives a Hold from Deutsche Bank

Deutsche Bank analyst Vijay Bhagavath upgraded Procera (NASDAQ: PKT) to Hold today and set a price target of $9. The company’s shares opened today at $9.75. Procera has an analyst consensus of Hold. The company has a one year high

Opower Receives a Buy from Canaccord Genuity

Canaccord Genuity analyst Richard Davis reiterated a Buy rating on Opower (NYSE: OPWR) today and set a price target of $23. The company’s shares opened today at $15. Opower has an analyst consensus of Hold. The company has a one

Deutsche Bank Believes ONNN Won’t Stop Here

Deutsche Bank analyst Ross Seymore reiterated a Buy rating on ON Semi (NASDAQ: ONNN) today and set a price target of $16. The company’s shares opened today at $12.91, close to its 52-week high of $13.07. Currently, the analyst consensus

NxStage Medical Recieves New Rating from Top Analyst

Canaccord Genuity analyst William Plovanic maintained a Buy rating on NxStage Medical (NASDAQ: NXTM) yesterday and set a price target of $27. The company’s shares opened today at $18.06, close to its 52-week high of $19.19. Plovanic wrote, “We were